The global cardiovascular implants market size reached US$ 26.1 billion in 2023. The market is projected to reach US$ 43.3 billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2023-2032. The rising prevalence of cardiovascular diseases, the expanding geriatric population, and significant advancements in the healthcare sector represent some of the key factors driving the market.
Cardiovascular implants are specialized medical tools used to treat various cardiovascular diseases (CVDs), including heart failure, coronary artery disease, peripheral arterial disease, aortic disease, and myocardial infarction. They are fitted inside the body to support the proper functioning of the heart and blood vessels and to alleviate symptoms associated with abnormal heart rhythms. These devices are made from titanium, pyrolytic carbon, silicone, and plastic mesh and are equipped with an implantable cardioverter-defibrillator (ICD) generator and wires that are insulated with polyurethane (PU) polymer. Cardiovascular implants can detect severe heart rhythms and send signals to maintain normal heart function.
2. What is the expected growth rate of the global cardiovascular implants market during 2024-2032?
3. What are the key factors driving the global cardiovascular implants market?
4. What has been the impact of COVID-19 on the global cardiovascular implants market?
5. What is the breakup of the global cardiovascular implants market based on the product type?
6. What is the breakup of the global cardiovascular implants market based on the indication?
7. What are the key regions in the global cardiovascular implants market?
8. Who are the key players/companies in the global cardiovascular implants market?
Cardiovascular implants are specialized medical tools used to treat various cardiovascular diseases (CVDs), including heart failure, coronary artery disease, peripheral arterial disease, aortic disease, and myocardial infarction. They are fitted inside the body to support the proper functioning of the heart and blood vessels and to alleviate symptoms associated with abnormal heart rhythms. These devices are made from titanium, pyrolytic carbon, silicone, and plastic mesh and are equipped with an implantable cardioverter-defibrillator (ICD) generator and wires that are insulated with polyurethane (PU) polymer. Cardiovascular implants can detect severe heart rhythms and send signals to maintain normal heart function.
Key Market Segmentation:
The report provides an analysis of the key trends in each sub-segment of the global cardiovascular implants market report, along with forecasts at the global and regional level from 2023-2032. The report has categorized the market based on product type, material, procedure type and indication.Product Type Insights:
- Coronary Stent
- ICD
- Heart Valve
- Implanted Cardiac Pacemaker
- CRT Device
- Peripheral Stent
Material Insights:
- Metals and Alloys
- Polymers
- Biological Materials
Procedure Type Insights:
- Angioplasty
- Open Heart Surgery
Indication Insights:
- Arrhythmias
- Myocardial Ischemia
- Acute Myocardial Infarction
- Congestive Heart Failure
- Others
Regional Insights:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- Latin America
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global cardiovascular implants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd.Key Questions Answered in This Report
1. How big is the global cardiovascular implants market?2. What is the expected growth rate of the global cardiovascular implants market during 2024-2032?
3. What are the key factors driving the global cardiovascular implants market?
4. What has been the impact of COVID-19 on the global cardiovascular implants market?
5. What is the breakup of the global cardiovascular implants market based on the product type?
6. What is the breakup of the global cardiovascular implants market based on the indication?
7. What are the key regions in the global cardiovascular implants market?
8. Who are the key players/companies in the global cardiovascular implants market?
Table of Contents
1 Preface3 Executive Summary12 Global Cardiovascular Implants Industry: Value Chain Analysis14 Global Cardiovascular Implants Industry: Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Cardiovascular Implants Market
6 Market Breakup by Product Type
7 Market Breakup by Material
8 Market Breakup by Procedure Type
9 Market Breakup by Indication
10 Market Breakup by Region
11 Global Cardiovascular Implants Industry: SWOT Analysis
13 Global Cardiovascular Implants Industry: Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- BIOTRONIK SE & Co. KG
- Abbott Laboratories
- AMG International
- B. Braun Melsungen AG
- Johnson & Johnson Services Inc.
- W. L. Gore & Associates Inc.
- Medtronic Private Limited
- Boston Scientific Corporation
- Sorin Corporation
- Edwards Lifesciences Corporation
- Fortimedix Surgical B.V.
- Neovasc Inc.
- CryoLife Inc.
- Proxy Biomedical Ltd.
- REVA Medical LLC.
- Shree Pacetronix Ltd.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 149 |
Published | January 2024 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 26.1 Billion |
Forecasted Market Value ( USD | $ 43.3 Billion |
Compound Annual Growth Rate | 5.8% |
Regions Covered | Global |
No. of Companies Mentioned | 16 |